Neurology

Ambulatory EHR Excellence: Top Vendors Recognized for Innovation and User Satisfaction in Black Book 2025 User Surveys

Top EHR Vendors Shine in Multiple Specialties: ModMed, NextGen Healthcare, Netsmart, ClinicMind, Epic, and RXNT Lead the Pack TAMPA, FLORIDA…

11 months ago

Emerging Specialty EHR Vendors Transform Clinical Workflows With Tailored Solutions, Insights From Black Book Research

54 Specialty EHR Vendors Across 17 Categories Mark New Entries in the 2024 Black Book Surveys with High Satisfaction Marks…

11 months ago

2025’s Top-Rated EHR Vendors Across 40 Medical & Surgical Specialties: Black Book Insights Into Innovation and Client-Centric Excellence

25 EHR Vendors Recognized Across 40 Physician Specialties, with ModMed, NextGen, Netsmart, ClinicMind, Epic, and RXNT Leading in Multiple Categories…

11 months ago

Radius Pharmaceuticals Announces Licensing Agreement with Pharmanovia to Register and Commercialize Abaloparatide in China and Select Asia Pacific Territories

BOSTON, MA / ACCESSWIRE / January 2, 2025 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc.…

11 months ago

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

IND submission for intranasal SPC-15 treatment expected in 2025; Phase 1 clinical trial to follow upon approvalSP-26 ketamine implants nearing…

11 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

PRINCETON, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that…

11 months ago

Lab Automation Market to Hit USD 7.71 Billion by 2029 with 6.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Dec. 18, 2024 /PRNewswire/ -- The global lab automation market is expected to reach USD 7.71 Billion by…

12 months ago

Noema Pharma Appoints Volker Knappertz, M.D., as Executive Vice President of Research & Development

BASEL, Switzerland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS)…

12 months ago

Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies

- Improvements Across Measures of Behavior, Function, Cognition and Movement - - Expediting Plans to Advance CT1812 into Late-Stage Trials…

12 months ago

NMD Pharma publishes new data on the role of ClC-1 inhibition in Charcot-Marie-Tooth in the Annals of Clinical and Translational Neurology

NMD Pharma publishes new data on the role of ClC-1 inhibition in Charcot-Marie-Tooth in the Annals of Clinical and Translational…

12 months ago